A market intelligence report by Transparency Market Research presents a comprehensive analysis of the global market for live cell imaging technologies.
The study of living cells with the help of detailed pictures produced by imaging systems such as microscopes and high content screening systems is called live cell imaging. Over the past few years, the use of LCI techniques across a number of research areas has consistently increased owing to the many benefits these techniques offer. LCI techniques are known to produce an enhanced view of a number of biological functions by giving insights into cellular dynamics of cellular processes.
Read Full Report: http://www.transparencymarketresearch.com/live-cell-imaging-market.html
LCI techniques are changing the way in which proteins, molecular interactions, cells, and a multitude of biological processes are studied. These techniques are aiding scientists to monitor in real time a variety of cellular structures and internal structures, thus providing a better understanding of dynamic processes and cellular structures, which is crucial for properly studying many aspects of cell biology.
The information compiled in the report finds huge scope in drug discovery, genetics, cytology, neurobiology, microbiology, and immunology. The rising adoption of LCI techniques in these fields, the rising popularity of high content screening technologies in the field of drug discovery, the rising prevalence of a number of cancers, and the rising volumes of funds by government bodies for cell-based research are driving the global market for LCI techniques.
However, certain factors such as the high cost of sophisticated screening systems and shortage of skilled professionals are hindering the overall development of the global live cell imaging market to a certain extent.
Download exclusive Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=7688
The report segments the market on the basis of four criteria: product type, technology, application, and geography.
On the basis of product type, the market is segmented into consumables, equipment, and software. Live cell imaging equipment are further classified into cell analyzers, standalone systems, image capturing devices, and microscopes. Of these, the segment of microscopes currently holds the largest share of the overall market. The consumables segment is bifurcated into assay kits, reagents, and media. Of these, the segment of assay kits currently holds the largest share in the overall LCI consumables market.
Technology-wise, the global live cell imaging market is segmented into FRAP (Fluorescence recovery after photo bleaching), PALM (Photo activated localization microscopy), TD-FLIM (Time-domain Fluorescence Lifetime Imaging Microscopy), FRET (Forster resonance energy transfer), TIRF (Total internal reflection fluorescence microscopy), and MPE (multiphoton excitation microscopy). On the basis of application, the market is segmented into wound healing, angiogenesis, chemotaxis, and cell culture under flow.
Request For Custom Research: http://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=7688
The report also presents a detailed overview of the competitive landscape of the global live cell imaging market with the help of detailed business profiles and SWOT analysis of some of the key companies in the market, recent development, and analysis of activities such as mergers and acquisitions, etc.
Some of the key companies in the market are Leica Microsystems, Carl Zeiss AG, Nikon Corporation, Molecular Devices, LCC, Becton, Dickinson and Company, Thermo Fisher Scientific, PerkinElmer, Inc., Sigma-Aldrich Corporation, and GE Healthcare.
